| 0.3084 0.016 (5.36%) | 07-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.4  |
1-year : | 0.47 |
| Resists | First : | 0.34 |
Second : | 0.4 |
| Pivot price | 0.22 |
|||
| Supports | First : | 0.23 |
Second : | 0.16 |
| MAs | MA(5) : | 0.27 |
MA(20) : | 0.22 |
| MA(100) : | 0.3  |
MA(250) : | 0.55 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 75.2 |
D(3) : | 71.9 |
| RSI | RSI(14): 66.1 |
|||
| 52-week | High : | 1.32 | Low : | 0.16 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed below upper band by 3.4%. Bollinger Bands are 80% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.35 - 0.35 | 0.35 - 0.35 |
| Low: | 0.29 - 0.29 | 0.29 - 0.3 |
| Close: | 0.31 - 0.31 | 0.31 - 0.31 |
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Mon, 13 Jul 2026
Cosmos Health's Bold Buyback: A Conviction Play or a Risky Bet? - Kavout | AI
Mon, 13 Jul 2026
Cosmos Health (COSM) Expands Share Repurchase Program with New B - GuruFocus
Mon, 13 Jul 2026
Cosmos Health Repurchases Additional 215,000 Shares Under $5 Million Buyback Program - Quiver Quantitative
Mon, 13 Jul 2026
Cosmos Health Inc. - Via Ritzau
Mon, 13 Jul 2026
Why Cosmos Health is still buying back its own stock at 32¢ a share - Stock Titan
Mon, 13 Jul 2026
Generic rival to Merck’s Januvia set for Greek rollout via Cosmos–Libytec deal - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 62 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 33.9 (%) |
| Held by Institutions | 5 (%) |
| Shares Short | 4,740 (K) |
| Shares Short P.Month | 890 (K) |
| EPS | -0.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.4 |
| Profit Margin | -30.5 % |
| Operating Margin | -12.2 % |
| Return on Assets (ttm) | -18.8 % |
| Return on Equity (ttm) | -92.4 % |
| Qtrly Rev. Growth | 30.7 % |
| Gross Profit (p.s.) | 0.11 |
| Sales Per Share | 1.11 |
| EBITDA (p.s.) | -0.27 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.47 |
| PEG Ratio | 0 |
| Price to Book value | 0.77 |
| Price to Sales | 0.27 |
| Price to Cash Flow | -2.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|